Research Article
Immediate Adverse Reactions to Gadolinium-Based MR Contrast Media: A Retrospective Analysis on 10,608 Examinations
Table 2
Population distribution for each GBCA.
| | | Gd-BT-DO3A | Gd-DOTA | Gd-BOPTA | Gd-DTPA | Gd-EOB-DTPA | value |
| | Age (mean ± range) | 59 (22–79) | 62 (29–78) | 56 (22–82) | 60 (22–84) | 61 (29–86) | 0.21 | | Gender (number of men/women) | 1771/1231 | 2106/1395 | 1051/761 | 483/323 | 895/592 | 0.59 | | No patients | 3002 | 3501 | 1812 | 806 | 1487 | | | Patient type (number of inpatients/outpatients) | 2350/652 | 2766/735 | 1409/403 | 624/182 | 1159/328 | 0.76 | | No patients premedicated | 510 | 596 | 299 | 136 | 244 | 0.89 | | No patients using concomitant drugs | 1350 | 1610 | 779 | 378 | 661 | 0.24 | | Iodinated CM hypersensitivity | 158 | 201 | 74 | 40 | 70 | 0.14 | | MRI examination type (abdomen/brain/head & neck/breast) | 1377/1405/0/220 | 3501/0/0/0 | 230/0/0/1582 | 726/0/80/0 | 1487/0/0/0 | <0.001 |
|
|
